Trevi Therapeutics Provides Update on Haduvio's Clinical Development Program
Go back to Trevi Therapeutics Provides Update on Haduvio's Clinical Development Program| (NASDAQ: TRVI) | Delayed: 18.26 -0.39 (2.09%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $18.65 | 52 Week High | $ | |||
| Open | $18.65 | 52 Week Low | $ | |||
| Day High | $18.82 | P/E | N/A | |||
| Day Low | $18.10 | EPS | $ | |||
| Volume | 869,023 | |||||

